Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
BioLineRx
May 26, 2020
BioLineRx Announces $9.0 Million Registered Direct Offering
Mar 06, 2020
BioLineRx to Report Annual 2019 Results on March 12, 2020
Jan 14, 2020
BioLineRx Receives Orphan Drug Designation for Motixafortide (BL-8040) for the Treatment of Pancreatic Cancer in Europe
Jan 08, 2020
BioLineRx to Present at the 2020 Biotech Showcase
Nov 26, 2019
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 5, 2019 in New York
Nov 06, 2019
BioLineRx to Report Third Quarter 2019 Results on November 11, 2019
Oct 31, 2019
BioLineRx to Present Two Posters at the Society for Immunotherapy of Cancer (SITC) 2019
Oct 29, 2019
BioLineRx to Deliver Oral Presentation at ESMO Immuno-Oncology Congress 2019
Sep 25, 2019
BioLineRx Announces Dosing of First Patient in Part 2 of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors
Sep 03, 2019
BioLineRx Successfully Completes Dose-Escalation Part of Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors
Jul 30, 2019
BioLineRx to Report Second Quarter 2019 Results on August 6, 2019
Jun 28, 2019
BioLineRx Announces Change in Ratio of American Depositary Shares to Ordinary Shares
Jun 13, 2019
BioLineRx to Present at the JMP Securities 2019 Life Sciences Conference
May 13, 2019
Frost & Sullivan Publishes Annual Update on BioLineRx
May 07, 2019
BioLineRx to Report First Quarter 2019 Results on May 14, 2019
Mar 21, 2019
BioLineRx to Report Annual 2018 Results on March 28, 2019
Mar 14, 2019
BioLineRx to Present at the 29th Annual Oppenheimer Healthcare Conference
Feb 12, 2019
Frost & Sullivan Publishes Immediate Report on BiolineRx
Feb 05, 2019
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
Feb 04, 2019
BioLineRx Announces Proposed Underwritten Public Offering of its American Depositary Shares and Warrants
Page 1
››
Latest News
Apr 26, 2024
OpenGate Capital Completes Sale of SMAC
Apr 26, 2024
Masonite Shareholders Approve Transaction with Owens Corning
Apr 26, 2024
Avery Dennison Increases Quarterly Dividend
Apr 26, 2024
ComEd Joins Bronzeville Community to Unveil New Public EV Chargers
Apr 26, 2024
OCOchem Advances Hydrogen Formate Electrolyzer Process By 10x To Create World’s Largest Industrial Scale CO2...
Apr 26, 2024
Canada Tractors Industry Analysis & Forecasts 2023-2024 and 2029: Technological Advancements and Shift...
Apr 26, 2024
Global and Regional Aircraft Fuel Cells Industry Research 2023-2033: Integration into Aircraft Systems Drives...
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events